PWPS
FENC icon

Pinnacle Wealth Planning Services’s Fennec Pharmaceuticals FENC Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.12K Hold
507
– – ﹤0.01% 2359
2025
Q4 		$3.9K Buy
+507
New +$4.16K ﹤0.01% 2341
2025
Q2 		– Sell
-15,419
Closed -$93.9K – 466
2025
Q1 		$93.9K Buy
15,419
+31
+0.2% +$199 0.01% 385
2024
Q4 		$97.3K Buy
+15,388
New +$78.8K 0.01% 371
2024
Q3 		– Sell
-12,289
Closed -$75.1K – 541
2024
Q2 		$75.1K Buy
+12,289
New +$102K 0.01% 491

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Pinnacle Wealth Planning Services's FENC Position: Q1 2026 in Review

Pinnacle Wealth Planning Services held its Fennec Pharmaceuticals (FENC) position steady in Q1 2026 at 507 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #2359.

Pinnacle Wealth Planning Services first reported a position in FENC in Q2 2024 and has held it in 5 quarters since. The position peaked at $97.3K in Q4 2024. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • Pinnacle Wealth Planning Services held 507 shares of Fennec Pharmaceuticals worth $3.12K as of Q1 2026.
  • Pinnacle Wealth Planning Services left its Fennec Pharmaceuticals share count unchanged in Q1 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #2359 holding.
  • Pinnacle Wealth Planning Services first reported a position in Fennec Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • Pinnacle Wealth Planning Services's Fennec Pharmaceuticals position peaked at $97.3K in Q4 2024.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.